World's Best Scientists 2026 revealed!
Takeshi Morimoto

Takeshi Morimoto

D-Index & Metrics

Medicine

D-Index
79
Citations
27713
World Ranking
17424
National Ranking
557

Takeshi Morimoto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Takeshi Morimoto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,020 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Takeshi Morimoto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Takeshi Morimoto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Takeshi Morimoto is affiliated with Kindai University in Japan and has contributed extensively to the field of medicine, with a primary focus on cardiology and cardiovascular medicine. Their research portfolio features a substantial number of publications addressing critical aspects of cardiovascular health, spanning various subfields including surgery, epidemiology, pulmonary and respiratory medicine, and internal medicine.

Their work engages deeply with key topics such as atrial fibrillation management and outcomes, venous thromboembolism diagnosis and management, acute ischemic stroke management, and coronary interventions and diagnostics. Antiplatelet therapy in cardiovascular diseases, acute myocardial infarction research, and cardiac imaging and diagnostics also represent prominent areas in their scholarly output.

Frequent publication venues for Takeshi Morimoto include several high-impact journals:

  • Circulation Journal
  • The American Journal of Cardiology
  • European Heart Journal
  • Circulation
  • Journal of the American Heart Association

Among recent papers associated with their research contributions are:

  • "Endovascular Therapy for Acute Stroke with a Large Ischemic Region" (2022, New England Journal of Medicine)
  • "Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome" (2022, JAMA Cardiology)
  • "Prevalence of post-intensive care syndrome among Japanese intensive care unit patients: a prospective, multicenter, observational J-PICS study" (2021, Critical Care)
  • "An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial" (2023, Circulation)
  • "Association with Controlling Nutritional Status (CONUT) Score and In-hospital Mortality and Infection in Acute Heart Failure" (2020, Scientific Reports)

Takeshi Morimoto has collaborated extensively with several researchers, frequently working alongside:

  • Takeshi Kimura
  • Kenji Andò
  • Kazushige Kadota
  • Yugo Yamashita
  • Hiroki Shiomi

The scope and depth of Morimoto's research contribute to ongoing studies in cardiovascular medicine with a particular emphasis on improving diagnostic and therapeutic strategies for acute and chronic cardiac conditions.

Best Publications

  • Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial

    Hisao Ogawa;Masafumi Nakayama;Takeshi Morimoto;Shiro Uemura

  • Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes : The J-CTO (Multicenter CTO Registry in Japan) Score as a Difficulty Grading and Time Assessment Tool

    Yoshihiro Morino;Mitsuru Abe;Takeshi Morimoto;Takeshi Kimura

  • Training and simulation for patient safety

    Rajesh Aggarwal;Oliver T. Mytton;Milliard Derbrew;David Hananel

  • Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial

    Hirotoshi Watanabe;Takenori Domei;Takeshi Morimoto;Masahiro Natsuaki

  • Adverse drug events and medication errors: detection and classification methods

    T Morimoto;T K Gandhi;A C Seger;T C Hsieh

  • Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome : A Multicenter Randomized Trial Evaluated by Volumetric Intravascular Ultrasound Using Pitavastatin Versus Atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] Study)

    Takafumi Hiro;Takeshi Kimura;Takeshi Morimoto;Katsumi Miyauchi

  • In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan).

    Yoshihiro Morino;Takeshi Kimura;Yasuhiko Hayashi;Toshiya Muramatsu

  • High Incidence of NLRP3 Somatic Mosaicism in Patients With Chronic Infantile Neurologic, Cutaneous, Articular Syndrome: Results of an International Multicenter Collaborative Study

    Naoko Tanaka;Kazushi Izawa;Megumu K. Saito;Mio Sakuma

  • Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.

    Peter M Rothwell;Nancy R Cook;Nancy R Cook;J Michael Gaziano;Jacqueline F Price

  • Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis.

    Tomohiko Taniguchi;Takeshi Morimoto;Hiroki Shiomi;Kenji Ando

  • Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study.

    Shunsuke Teraoka;Daichi Fujimoto;Takeshi Morimoto;Hayato Kawachi

  • Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.

    Takeshi Kimura;Takeshi Morimoto;Yoshihisa Nakagawa;Kazuya Kawai

  • Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents Observations From the Registry of Stent Thrombosis for Review and Reevaluation (RESTART)

    Takeshi Kimura;Takeshi Morimoto;Ken Kozuma;Yasuhiro Honda

  • Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent : A Randomized, Controlled, Noninferiority Trial

    Masahiro Natsuaki;Ken Kozuma;Takeshi Morimoto;Kazushige Kadota

  • Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection.

    Yasuhiro Kodera;Yoshitaka Yamamura;Yasuhiro Shimizu;Akihito Torii

  • An evaluation of risk factors for adverse drug events associated with angiotensin‐converting enzyme inhibitors

    Takeshi Morimoto;Takeshi Morimoto;Takeshi Morimoto;Tejal K. Gandhi;Tejal K. Gandhi;Julie M. Fiskio;Andrew C. Seger

  • Survival after curative resection for mucinous adenocarcinoma of the colorectum.

    Yukihide Kanemitsu;Tomoyuki Kato;Takashi Hirai;Kenzo Yasui

  • Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study

    Hiroki Shiomi;Yoshihisa Nakagawa;Takeshi Morimoto;Yutaka Furukawa

  • Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis: A Randomized Clinical Trial.

    Yu Kawazoe;Kyohei Miyamoto;Takeshi Morimoto;Tomonori Yamamoto

  • Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET)

    Takeshi Kimura;Takeshi Morimoto;Masahiro Natsuaki;Hiroki Shiomi

Frequent Co-Authors

Takeshi Kimura
Takeshi Kimura Kyoto University
Yasuhiro Kodera
Yasuhiro Kodera Nagoya University
Toru Kita
Toru Kita Kyoto University
Hisao Ogawa
Hisao Ogawa Kumamoto University
Minoru Horie
Minoru Horie Shiga University of Medical Science
Yoshihiko Saito
Yoshihiko Saito Nara Medical University
Atsushi Nakagawa
Atsushi Nakagawa Osaka University
David W. Bates
David W. Bates Brigham and Women's Hospital
Toshio Heike
Toshio Heike Kyoto University
Masunori Matsuzaki
Masunori Matsuzaki Yamaguchi University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the healthcare field, but not sure if medical school is the right path? There are several affordable and rewarding online programs that can launch your career in healthcare, even without a medical degree.

Technology-driven students may consider a health information technology online degree. This pathway prepares you for roles managing patient records, data security, and healthcare IT systems.

If you’re detail-oriented, look into the medical coding certification cost and programs. These certifications allow you to work in medical billing and coding, which are vital for the business side of healthcare.

For those aiming to provide direct care, there are many cheapest fnp programs online that train you to become a Family Nurse Practitioner—a high-demand, advanced nursing role.

If nursing appeals to you and you want to fast-track your education, explore the cheapest online accelerated bsn programs. These programs help you become a registered nurse in less time, with flexible online options.

Exploring these online degrees opens doors to fulfilling, high-impact careers in healthcare—often at a lower cost and with greater convenience than traditional medical school.

Best Scientists Citing Takeshi Morimoto

Trending Scientists

Recently Published Articles